PharmaShots Weekly Snapshots (May 10 – 14, 2021)

 PharmaShots Weekly Snapshots (May 10 – 14, 2021)

AzurRx BioPharma Reports Positive Interim P-II Data of MS1819 + PERT for Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

Published: May 14, 2021 | Tags: AzurRx BioPharma, P-II, MS1819, PERT, Cystic Fibrosis, Severe, Exocrine Pancreatic Insufficiency

Goldfinch Bio Initiates P-I Clinical Trial of GFB-024 for the Treatment of Severe Insulin Resistant Diabetic Nephropathy

Published: May 14, 2021 | Tags: Goldfinch Bio, P-I, Clinical Trial, GFB-024, Severe Insulin Resistant Diabetic Nephropathy

Reistone Reports First Patient Dosing in P-III RSJ10333 Trial of SHR0302 for the Treatment of Atopic Dermatitis

Published: May 14, 2021 | Tags: Reistone, P-III, RSJ10333 Trial, SHR0302, Atopic Dermatitis

Heron Therapeutics’ ZYNRELEF (HTX-011) Receives the US FDA’s Approval for the Management of Postoperative Pain

Published: May 14, 2021 | Tags: Heron Therapeutics, Zynrelef, HTX-011, US, FDA, Approval, Postoperative Pain

Novo Nordisk Reports Results of Semaglutide from P-IIIa STEP 1 Trial in Patients with Obesity

Published: May 14, 2021 | Tags: Novo Nordisk, Semaglutide, P-IIIa, STEP 1 Trial, Obesity

Biogen and Envisagenics Enter into a Collaboration for the Advancement of RNA Splicing Research to Treat Central Nervous System Diseases

Published: May 14, 2021 | Tags: Biogen, Envisagenics, RNA Splicing Research, AI Technology, Central Nervous System Diseases

Dr Reddy’s Acquires an Exclusive License for Pregene’s PRG1801 in India

Published: May 13, 2021 | Tags: Dr. Reddy’s, Exclusive License, Pregene, PRG1801, India

Fulcrum Therapeutics’ Losmapimod Receives the US FDA’s Fast Track Designation to Treat Facioscapulohumeral Muscular Dystrophy

Published: May 13, 2021 | Tags: Fulcrum Therapeutics, US FDA, Fast Track Designation, Losmapimod, Facioscapulohumeral Muscular Dystrophy

AstraZeneca and Amgen Present Results of Tezepelumab in P-III NAVIGATOR Study for Severe Asthma at ATS2021

Published: May 13, 2021 | Tags: AstraZeneca, Amgen, Tezepelumab, P-III, NAVIGATOR Study, Severe Asthma, ATS2021

Antengene Receives IND Approval for P-III SIENDO Trial of XPOVIO (Selinexor) to Treat Advanced or Recurrent Endometrial Cancer in China

Published: May 13, 2021 | Tags: Antengene, IND, Approval, P- III, SIENDO Trial, Selinexor, Advanced, Recurrent Endometrial Cancer

Biogen Exercises its Option to Acquire TMS-007 for Acute Ischemic Stroke

Published: May 13, 2021 | Tags: Biogen, TMS, TMS-007, Acute Ischemic Stroke, Acquisition

Regeneron and Sanofi Present Positive Results of Libtayo (cemiplimab) from P-III Trial for Cervical Cancer at ESMO2021

Published: May 13, 2021 | Tags: Regeneron, Sanofi, Libtayo, cemiplimab, P-III, Trial, Cervical Cancer, ESMO2021

InflaRx Reports Results of Vilobelimab in P- II IXPLORE Study in Patients with Anti-Neutrophil Cytoplasmic Autoantibody Associated Vasculitis

Published: May 12, 2021 | Tags: InflaRx, Vilobelimab, P- II, IXPLORE Study, Anti-Neutrophil Cytoplasmic Auto-Antibody, Vasculitis

Medtronic Launches SonarMed Airway Monitoring System to Detect Airway Obstruction During Ventilation in Pediatric Patients

Published: May 12, 2021 | Tags: Medtronic, SonarMed Airway Monitoring System, Airway Obstruction, Ventilation, Pediatric Patients

Nanobiotix Collaborates with Lianbio to Develop and Commercialize NBTXR3 in China and other Asian Countries

Published: May 12, 2021 | Tags: Nanobiotix, Lianbio, NBTXR3, Head & Neck Squamous Cell Carcinoma, China, Korea, Singapore, Thailand

Incyte and MorphoSys Report First Patient Dosing in P-III frontMIND Study of Tafasitamab + Lenalidomide as a 1L Treatment for DLBCL

Published: May 12, 2021 | Tags: Incyte, MorphoSys, P-III, frontMIND Study, Tafasitamab, Lenalidomide, DLBCL

Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials

Published: May 12, 2021 | Tags: Cellectis, Sanofi, Alemtuzumab, CART-Cell Trials

Autobahn Acquires Global Rights to Astellas’ ASP3652 to Bolster its Brain Targeting Chemistry Platform

Published: May 12, 2021 | Tags: Autobahn, Global Rights, Astellas, ASP3652, Brain Targeting Chemistry Platform

Lilly Signs a ~$1.25B Research Collaboration with MiNA Therapeutics to Develop saRNA Therapies

Published: May 11, 2021 | Tags: Lilly, ~$1.25B, MiNA Therapeutics, saRNA Therapies

Biogen Collaborates with Capsigen to Discover Novel AAV Capsids for Targeted CNS and Neuromuscular Disorders

Published: May 11, 2021 | Tags: Biogen, Capsigen, Novel AAV Capsids, CNS, Neuromuscular Disorders

Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M

Published: May 11, 2021 | Tags: Allergan Aesthetics, Soliton, Resonic Device, ~$550M

AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma

Published: May 11, 2021 | Tags: AstraZeneca, Amgen, BLA, US, FDA, Tezepelumab, Severe Asthma

Pfizer and BioNTech Receive the US FDA’s EMA for COVID-19 Vaccine in Adolescents

Published: May 11, 2021 | Tags: Pfizer, BioNTech, US, FDA, EMA, COVID-19 Vaccine, Adolescents

Bayer Reports Results of Finerenone in P- III FIGARO-DKD CV Outcomes Study for Chronic Kidney Disease and Type 2 Diabetes

Published: May 11, 2021 | Tags: Bayer, Finerenone, P- III, FIGARO-DKD CV Outcomes Study, Chronic Kidney Disease, Type 2 Diabetes

Aurinia Publishes the Results of Lupkynis (voclosporin) in P-III AURORA 1 Study for Patients with Active Lupus Nephritis in The Lancet

Published: May 10, 2021 | Tags: Aurinia, Lupkynis, voclosporin, P-III, AURORA 1 Study, Active Lupus Nephritis, The Lancet

Pfizer and BioNTech Initiate Rolling Submission of BLA for the US FDA’s Approval of their COVID-19 Vaccine

Published: May 10, 2021 | Tags: Pfizer, BioNTech, BLA, US, FDA, Approval, COVID-19 Vaccine

Walmart Health Signs an Agreement to Acquire MeMD for its Telehealth Services

Published: May 10, 2021 | Tags: Walmart Health, MeMD, Telehealth Services

Eli Lilly Signs an International Agreements with Four Diabetes Technology Companies for Connected Insulin Pen Solutions

Published: May 10, 2021 | Tags: Eli Lilly, Diabetes Technology Companies, Connected, Insulin Pen Solutions

BD to Spin Off its Diabetes Care Business into New Public Company

Published: May 10, 2021 | Tags: BD, Spin Off, Diabetes Care Business, New Public Company

GSK and Vir Report Initiation of EMA Rolling Review of VIR-7831 (sotrovimab) for the Early Treatment of COVID-19

Published: May 10, 2021 | Tags: GSK, Vir, EMA, VIR-7831, sotrovimab, COVID-19

Related Post: PharmaShots Weekly Snapshots (May 03 – 07, 2021)

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post